Cardio Diagnostics Holdings, Inc. (CDIO) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $29.00; Additional Paid in CapitalUSD $39.97M; Retained Earnings (Accumulated Deficit)USD $-32.54M; Stockholders' Equity Attributable to ParentUSD $7.43M.
- 2026-03-31: Common Stock, Value, IssuedUSD $29.00; Additional Paid in CapitalUSD $39.94M; Retained Earnings (Accumulated Deficit)USD $-31.04M; Stockholders' Equity Attributable to ParentUSD $8.90M.
- 2025-12-31: Common Stock, Value, IssuedUSD $18.00; Additional Paid in CapitalUSD $36.22M; Retained Earnings (Accumulated Deficit)USD $-29.25M; Stockholders' Equity Attributable to ParentUSD $6.97M.
- 2025-09-30: Common Stock, Value, IssuedUSD $18.00; Additional Paid in CapitalUSD $35.94M; Retained Earnings (Accumulated Deficit)USD $-27.78M; Stockholders' Equity Attributable to ParentUSD $8.15M.
Cardio Diagnostics Holdings, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Preferred Stock, Value, Issued USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29.00 | $39.97M | $-32.54M | $7.43M | (m) | (m) |
| 2026-03-31 | $29.00 | $39.94M | $-31.04M | $8.90M | (m) | (m) |
| 2025-12-31 | $18.00 | $36.22M | $-29.25M | $6.97M | (m) | (m) |
| 2025-09-30 | $18.00 | $35.94M | $-27.78M | $8.15M | (m) | (m) |
| 2025-06-30 | $17.00 | $35.79M | $-26.07M | $9.72M | (m) | (m) |
| 2025-03-31 | $17.00 | $35.76M | $-24.39M | $11.38M | (m) | (m) |
| 2024-12-31 | $15.00 | $32.31M | $-22.75M | $9.56M | (m) | (m) |
| 2024-09-30 | $303.00 | $24.92M | $-21.23M | $3.69M | (m) | (m) |
| 2024-06-30 | $233.00 | $22.89M | $-19.82M | $3.07M | (m) | (m) |
| 2024-03-31 | $216.00 | $21.57M | $-18.53M | $3.04M | (m) | (m) |
| 2023-12-31 | $205.00 | $17.33M | $-14.37M | $2.96M | (m) | (m) |
| 2023-09-30 | $131.00 | $15.27M | $-12.98M | $2.29M | $0.00 | (m) |
| 2023-06-30 | $112.00 | $13.96M | $-11.05M | $2.91M | $0.00 | (m) |
| 2023-03-31 | $96.00 | $10.45M | $-7.02M | $3.42M | (m) | (m) |
| 2022-12-31 | $95.00 | $10.29M | $-5.99M | $4.30M | $0.00 | (m) |
| 2022-09-30 | $16.00 | $394.22K | $-747.93K | $9.57M | $0.00 | (m) |
| 2022-06-30 | $16.00 | $827.55K | $-860.15K | $9.70M | $0.00 | (m) |
| 2022-03-31 | $16.00 | $827.55K | $-367.50K | $778.05K | $0.00 | (m) |
| 2021-12-31 | $16.00 | $2.40M | $-1.33M | $1.07M | $0.00 | (m) |
| 2021-11-30 | (m) | (m) | (m) | (m) | (m) | 1 month · $397.43K |
| 2021-09-30 | (m) | (m) | (m) | $24.28K | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | $24.60K | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | $60.37K | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |